Zion Market Research has published a new report titled “Stroke Diagnostics and Therapeutics Market by Diagnostics (Magnetic Resonance Imaging, Computed Tomography Scan, Electrocardiography Carotid Ultrasound, Cerebral Angiography and Others) by Therapeutics (Tissue Plasminogen Activator, Antiplatelet, Antihypertensive, and Anticoagulant) for Haemorrhagic Stroke and Ischemic Stroke – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global stroke diagnostics and therapeutics market accounted for USD 21.50 billion in 2015 and is expected to reach USD 31.00 by 2021, growing at a CAGR of approximately 7.0% between 2015 and 2021.

The key participants operating in the global stroke diagnostics and therapeutics market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck & Co., Inc.

For More Info: https://goo.gl/m6w7mz

Source: Click here

Facebook Comments